Screener
Nuvation Bio NUVB CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireMachineryAndEquipment.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| For the Six Months Ended June 30, | 2026 | 2025 |
|---|---|---|
| Cash flow from investing activities: | ||
| Purchases of marketable securities | (149,840) | (142,378) |
| Proceeds from sale of marketable securities | 112,497 | 251,689 |
| Purchases of property and equipment | (302) | (253) |
| Net cash (used in) provided by investing activities | (37,645) | 109,058 |
| Cash flow from financing activities: | ||
| Proceeds from borrowings, net of debt issuance costs and debt discounts | — | 48,901 |
| Proceeds from revenue interest financing agreement | — | 150,000 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's capex?
- Nuvation Bio (NUVB) reported capex of $254K in Q2 2026.
- How has Nuvation Bio's capex changed year-over-year?
- Nuvation Bio's capex increased by 40.3% year-over-year, from $181K to $254K.
- What is the long-term trend for Nuvation Bio's capex?
- Over 4 years (2021 to 2025), Nuvation Bio's capex has grown at a 130.8% compound annual growth rate (CAGR), from $282K to $8M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Nuvation Bio's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude